颅内动脉瘤市场份额、大小、趋势、行业分析报告、按类型（外科夹闭、血管内卷取、分流器等）、按最终用途（医院、诊所等）；按地区；2021-2028年细分预测

Report Summary

2020年，全球颅内动脉瘤市场价值为11.2亿美元，预计在预测期内复合年增长率为9.9%。颅内动脉瘤是大脑中动脉的扩张，导致气泡、气球和扩张。

颅内动脉瘤主要发生在向脑血管供氧的动脉中。吸烟、饮酒、血管损伤和遗传易感性是颅内动脉瘤形成的主要原因。目前的治疗方法包括血管内缠绕、药物治疗和外科夹闭。

Know more about this report:样本页请求

推动颅内动脉瘤市场增长的因素包括：患心血管疾病的人数不断增加，错误的生活方式，以及越来越多的患者选择微创手术。错误和忙碌的生活方式加上高血压显著增加了发生这种动脉瘤的风险。

Currently, a large section of the population who have been smoking and drinking for the last few years, have higher chances of a intracranial aneurysm. For instance, according to WHO, in 2019, around 1.1 billion people were suffering from hypertension. Moreover, the population all across the globe is aging faster than expected, hence, major consumption of intracranial devices is expected to grow over the forecast period.

产业动态

增长动力
越来越多的人患有高血压和高血压，预计这将是市场的一个突出因素。根据NCBI的研究，老年人颅内动脉瘤的患病率正在迅速上升。据世卫组织预测，2018年，到2050年，老年人口预计将增至20亿。因此，如此庞大的人口基数有望成为影响颅内动脉瘤市场未来发展的关键因素。

Nowadays, minimally invasive surgeries among patients are gaining importance, owing to their less risk and complications. Finer and smaller incisions decrease post-operative pain and promote faster recovery, thus led to its rapid adoption and has triggered R&D investments among market players. Big players are investing heavily to introduce minimal invasive devices.

例如，2019年12月，美国食品和药物管理局批准了血管内装置Woven EndoBridge（WEB）用于治疗最具挑战性的颅内动脉瘤。WEB是一种独特的设备，它允许分流和动脉瘤，一个由编织的金属丝组成的球体，看起来像一个弹簧篮，通过一根微创导管插入动脉瘤。

网络模拟动脉瘤的形状，阻止血液流动，并允许血管愈合。整个手术过程大约需要50分钟，这与传统的干预措施相比要少得多。除了能够减少手术时间外，它还可以减少病人在麻醉下的时间、暴露于辐射和造影剂的时间，并将并发症的发生率降到最低。

颅内动脉瘤市场报告范围

The market is primarily segmented on the basis of type, end-use, and region.

按类型	By End-Use	By Region
外科夹 Endovascular Coiling Flow Diverters 其他	Hospitals 诊所 其他	North America (U.S., Canada) Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) 亚太地区（日本、中国、印度、马来西亚、印度尼西亚、韩国） 拉丁美洲(巴西、墨西哥、基于“增大化现实”技术gentina) Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Know more about this report:样本页请求

按类型细分

Based on type, the intracranial aneurysm market is classified into endovascular coiling, surgical clipping, flow diverters, and others. In 2020, endovascular coiling held the largest revenue market share. Such segmental market growth was attributed to the growing preference of individuals towards minimally invasive procedures and benefits offered by endovascular coiling. It offers easy access to the vertebra-basilar region for multiple aneurysms within a short recovery time as compared to others. Hence, such benefits are expected to fuel the segment’s growth prospects.

The分流器market segment is projected to register the highest growth rate over the study period. The consistent launch of products over the last few years have prompted the adoption of flow diverters. For instance, in August 2020, the U.S.-based medical device manufacturer introduced its first 64 wired Surpass Evolve flow diverter, designed specifically to redirect blood flow to promote self-healing of aneurysms. Earlier, in July 2018, Balt received approval for its Silk Vista flow diversion stent to treat unruptured aneurysms. Such initiatives are expected to fruitful results in the future.

按最终用途细分

根据最终用途，市场分为医院、诊所和其他。预计到2020年，医院市场将占据最大份额。医院的迅速普及是由于手术数量的增加以及有资金购买这类市场产品。这些设备不仅简化了手术程序，而且有助于提供更快和准确的结果。此外，这些手术被认为是最复杂的手术之一，医院也配备有术后并发症。

Geographic Overview

North America market is estimated to hold the maximum share in the global market. Regional market factors responsible for such growth include the rising prevalence of intracranial aneurysms in the U.S. and Canada, increasing incidence of hypertension and stroke, and rapidly aging population. Moreover, the presence of robust healthcare facilities in the region also favored its market growth.

As per the market estimates of Neuro Intervention India, in 2017, in the U.S. alone around 6 million people had un-ruptured intracranial aneurysms. It is also being reported that each year, approximately, 30,000 people in the U.S. die with a ruptured intracranial aneurysm. Similarly, as per estimates of the Brain Aneurysm Foundation, in Canada, each year approximately 2,800 to 3,500 individuals suffer from an intracranial aneurysm.

Competitive Insight

Some of the major players operating the market for intracranial aneurysm are MicroVention Inc. (Terumo Corporation), B. Braun, Stryker, Medtronic, Johnson and Johnson Services Inc., Microport Scientific Corporation, and Codman Neuro (Integra Lifesciences).